Recombinant monoclonal antibody to CD16/CD32. Manufactured using recombinant technology with variable regions (i.e. specificity) from the hybridoma 2.4G2. This antibody binds murine Fc Receptors CD16/CD32 and inhibits binding of antibodies to these. It can therefore be used as an Fc-blocking reagent，to reduce non-specific staining of cells by antibodies binding via their Fc-region.
